PASADENA, Calif.--(BUSINESS WIRE)--Sanguine Corporation (OTC Bulletin Board: SGNC - News) is pleased to announce that it will be opening an office in West Chester, Pennsylvania, to expand its operations and to secure east coast representation. The West Chester office will house Sanguine’s newly formed life sciences division. The focus of the life sciences division is to advance SGNC through the development and acquisition of projects and technologies that will produce revenue for the Company. The West Chester office will also be increasing the current efforts to commercialize Sanguine’s flagship product, PHER-02.
